FDA inspection
Angelini Pharma, Inc.: FDA inspection ending Mar 17, 2015
FDA inspection 920215 · Voluntary Action Indicated (VAI) · Atlanta, GA
Key facts
| Inspection ID | 920215 |
|---|---|
| Firm | Angelini Pharma, Inc. |
| FEI number | 3001239013 |
| Address | 9200 Corporate Blvd Ste 100 |
| City | Atlanta |
| State | GA |
| ZIP | 30303 |
| Country | United States |
| Fiscal year | 2015 |
| Inspection end date | Mar 17, 2015 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data